About
DermaSensor, Inc. is a health technology company based in Miami, founded in 2009. The company focuses on improving access to skin cancer assessments by providing advanced diagnostic tools for frontline healthcare providers. Their flagship product is an FDA-cleared, CE-marked automated medical device that uses patented elastic scattering spectroscopy (ESS) technology combined with artificial intelligence to scan skin lesions for malignancy. This handheld device delivers quick, objective risk assessments for common skin cancers within about 30 seconds. Designed for use in various healthcare settings, including primary care, the device offers recommendations such as “Investigate Further” or “Monitor” based on the risk level of the lesion. DermaSensor's technology aims to enhance early diagnosis and timely referrals, ultimately improving patient outcomes. The company has equipped numerous physicians with its device, enabling faster and more accurate skin cancer detection at the point of care.
Technologies
Keywords
Company Information
-
Employees 27
-
Founded 2009
-
Total Funding $63893541
Location
950 Brickell Bay Dr, Miami, Florida, United States, 33131